Question 1

What specific types of cancer are eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies clinical trial (NCT03241173). Contact the study team or your healthcare provider for specific answers.

Question 2

How does INCAGN01949 work compared to my current treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies clinical trial (NCT03241173). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies clinical trial (NCT03241173). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies clinical trial (NCT03241173). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies clinical trial (NCT03241173). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or travel requirements I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies clinical trial (NCT03241173). Contact the study team or your healthcare provider for specific answers.

What this study is about